KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Retained Earnings: 2017-2025

Historic Retained Earnings for Aquestive Therapeutics (AQST) over the last 8 years, with Sep 2025 value amounting to -$415.1 million.

  • Aquestive Therapeutics' Retained Earnings fell 19.93% to -$415.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$415.1 million, marking a year-over-year decrease of 19.93%. This contributed to the annual value of -$363.2 million for FY2024, which is 13.83% down from last year.
  • Aquestive Therapeutics' Retained Earnings amounted to -$415.1 million in Q3 2025, which was down 3.86% from -$399.7 million recorded in Q2 2025.
  • Aquestive Therapeutics' Retained Earnings' 5-year high stood at -$200.9 million during Q1 2021, with a 5-year trough of -$415.1 million in Q3 2025.
  • Moreover, its 3-year median value for Retained Earnings was -$334.6 million (2024), whereas its average is -$347.2 million.
  • Data for Aquestive Therapeutics' Retained Earnings shows a maximum YoY tumbled of 42.83% (in 2021) over the last 5 years.
  • Aquestive Therapeutics' Retained Earnings (Quarterly) stood at -$256.8 million in 2021, then dropped by 21.19% to -$311.2 million in 2022, then fell by 2.53% to -$319.1 million in 2023, then declined by 13.83% to -$363.2 million in 2024, then dropped by 19.93% to -$415.1 million in 2025.
  • Its Retained Earnings was -$415.1 million in Q3 2025, compared to -$399.7 million in Q2 2025 and -$386.1 million in Q1 2025.